Researchers discovered that gut microbiota-derived hexa-acylated LPS enhances the effectiveness of anti-PD-1 cancer ...

Researchers reveal that gut microbiota influence the effectiveness of immune checkpoint inhibitors (ICIs) in cancer treatment ...

A new computational tool could help researchers identify promising drug combinations for treating cancer, according to a new ...

Scientists have developed retriever, a computational tool that extracts disease-specific drug response signatures to predict the best combinations for cancer treatment.

According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...

Two enzyme inhibitors join forces in reducing bladder cancer cell proliferation. n 1996, molecular biologist Kun Ping Lu, a ...

The authors report that DopR1 and Dop2R receptors, which have opposing effects in intracellular cAMP, are present in axons termini of Kenyon cells, as well as those of two classes of dopaminergic ... ...

PADCEV is an antibody-drug conjugate (ADC) that delivers cell-killing medicine directly to certain cancer cells. [7] However, it can also affect normal cells and cause side effects. PADCEV is a ...

A phase 2, multicenter, open-label study of AlloStim combined with anti-PD-L1 immunotherapy as 4L therapy in patients with MSS/pMMR metastatic colorectal cancer. This is an ASCO Meeting Abstract from ...

This study was aimed at gaining important new insights into the heterogeneity of epithelial and immune cells and elucidating key regulatory genes involved in the pathogenesis of asthma exacerbation.

People who support using hydrogen peroxide to treat cancer claim that it kills cancer cells by flooding them with oxygen. This type of treatment is also called: bio-oxidative therapy ...

1Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, California.